Synapse

← Cancer Research Communications

Papers in Cancer Research Communications

Page 11 · newest first

  1. mTORC1-driven protein translation correlates with clinical benefit of capivasertib within a genetically preselected cohort of PIK3CA-altered tumoursCancer Research Communications · 2024
  2. PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization Under Microenvironmental PressureCancer Research Communications · 2024
  3. N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung CarcinomaCancer Research Communications · 2024
  4. Inhibition of Notch4 using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumCancer Research Communications · 2024
  5. A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCCCancer Research Communications · 2024
  6. E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response NetworkCancer Research Communications · 2024
  7. Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional SignaturesCancer Research Communications · 2024
  8. Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin LymphomaCancer Research Communications · 2024
  9. Putrescine supplementation limits the expansion of pks+ Escherichia coli and tumor development in the colonCancer Research Communications · 2024
  10. A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)Cancer Research Communications · 2024
  11. Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell CarcinomaCancer Research Communications · 2024
  12. The effect of exposure to neighborhood violence on Glucocorticoid Receptor signaling in lung tumorsCancer Research Communications · 2024
  13. The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal CancerCancer Research Communications · 2024
  14. KRAS promotes GLI2-dependent transcription during pancreatic carcinogenesisCancer Research Communications · 2024
  15. Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral FibrosisCancer Research Communications · 2024
  16. Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in MelanomaCancer Research Communications · 2024
  17. Characterization of non-monotonic relationships between tumor mutational burden and clinical outcomesCancer Research Communications · 2024
  18. Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate MicronucleiCancer Research Communications · 2024
  19. Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate CancerCancer Research Communications · 2024
  20. Epigenetic induction of cancer testis antigens and endogenous retroviruses at single-cell level enhances immune recognition and response in gliomaCancer Research Communications · 2024
  21. Noninvasive lung cancer subtype classification using tumor-derived signatures and cfDNA methylomeCancer Research Communications · 2024
  22. Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide studyCancer Research Communications · 2024
  23. Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1Cancer Research Communications · 2024
  24. The TERT promoter is polycomb-repressed in neuroblastoma cells with long telomeresCancer Research Communications · 2024
  25. Cancer related fatigue and the additive effect of treatment in the context of lymphoma: An analysis of the Lymphoma Coalition’s 2022 Global Patient SurveyCancer Research Communications · 2024
  26. Multi-omics analysis of a fecal microbiota transplantation trial identifies novel aspects of acute graft-versus-host disease pathogenesisCancer Research Communications · 2024
  27. Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecological CancersCancer Research Communications · 2024
  28. Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionCancer Research Communications · 2024
  29. Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort EvaluationCancer Research Communications · 2024
  30. Mechanistic Characterization of Cancer Associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation ProteinCancer Research Communications · 2024
  31. HDAC6 inhibition releases HR23B to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activityCancer Research Communications · 2024
  32. Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy ResponseCancer Research Communications · 2024
  33. Epigenetic priming by hypomethylation enhances the immunogenic potential of tolinapant in T-cell lymphomaCancer Research Communications · 2024
  34. Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade ResponseCancer Research Communications · 2024
  35. LYVE-1-expressing macrophages modulate the hyaluronan-containing extracellular matrix in the mammary stroma and contribute to mammary tumor growthCancer Research Communications · 2024
  36. Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancerCancer Research Communications · 2024
  37. B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid TumorsCancer Research Communications · 2024
  38. Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft ModelsCancer Research Communications · 2024
  39. Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCancer Research Communications · 2024
  40. Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaCancer Research Communications · 2024
  41. Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer RecurrenceCancer Research Communications · 2024
  42. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical ImplicationsCancer Research Communications · 2024
  43. Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsCancer Research Communications · 2024
  44. A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal MelanomaCancer Research Communications · 2024
  45. Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric CancerCancer Research Communications · 2024
  46. First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley StudyCancer Research Communications · 2024
  47. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast CancerCancer Research Communications · 2024
  48. Mutant RAS-driven Secretome Causes Skeletal Muscle Defects in Breast CancerCancer Research Communications · 2024
  49. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with GlioblastomaCancer Research Communications · 2024
  50. Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancersCancer Research Communications · 2024